Caroline Jacoby Schmidt, Laura Silveira de Moura, Paulo de Tarso Roth Dalcin, Bruna Ziegler
{"title":"CFTR调节剂时代囊性纤维化治疗面临的挑战作者回复在囊性纤维化且至少有一个F508del等位基因的患者中使用eexacaftor+tezacaftor+ivacaftor的系统综述和荟萃分析在接受调节剂治疗的囊性纤维化患者中停用与继续使用高渗盐水或dornase alfa(SIMPLIFY)两项平行、多中心、开放标签、随机对照、非劣效性试验的结果评估停用高渗盐水对用力呼气容积降低者的安全性多中心、开放标签、随机对照、非劣效试验评估停用高渗盐水对 Elexacaftor/Tezacaftor/Ivacaftor 治疗后 1 秒内用力呼气容积降低者的安全性。","authors":"Caroline Jacoby Schmidt, Laura Silveira de Moura, Paulo de Tarso Roth Dalcin, Bruna Ziegler","doi":"10.36416/1806-3756/e20240107","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14845,"journal":{"name":"Jornal Brasileiro De Pneumologia","volume":"50 2","pages":"e20240107"},"PeriodicalIF":2.9000,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185157/pdf/","citationCount":"0","resultStr":"{\"title\":\"Challenges in the treatment of cystic fibrosis in the era of CFTR modulatorsAuthors' replyUse of elexacaftor+tezacaftor+ivacaftor in individuals with cystic fibrosis and at least one F508del allele a systematic review and meta-analysisDiscontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY) results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trialsAssessing Safety of Discontinuing Hypertonic Saline in Those with Lower Forced Expiratory Volume in 1 Second after Elexacaftor/Tezacaftor/Ivacaftor.\",\"authors\":\"Caroline Jacoby Schmidt, Laura Silveira de Moura, Paulo de Tarso Roth Dalcin, Bruna Ziegler\",\"doi\":\"10.36416/1806-3756/e20240107\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":14845,\"journal\":{\"name\":\"Jornal Brasileiro De Pneumologia\",\"volume\":\"50 2\",\"pages\":\"e20240107\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-05-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185157/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Jornal Brasileiro De Pneumologia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.36416/1806-3756/e20240107\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jornal Brasileiro De Pneumologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36416/1806-3756/e20240107","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
Challenges in the treatment of cystic fibrosis in the era of CFTR modulatorsAuthors' replyUse of elexacaftor+tezacaftor+ivacaftor in individuals with cystic fibrosis and at least one F508del allele a systematic review and meta-analysisDiscontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY) results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trialsAssessing Safety of Discontinuing Hypertonic Saline in Those with Lower Forced Expiratory Volume in 1 Second after Elexacaftor/Tezacaftor/Ivacaftor.
期刊介绍:
The Brazilian Journal of Pulmonology publishes scientific articles that contribute to the improvement of knowledge in the field of the lung diseases and related areas.